Search results for "Ventricular hypertrophy"

showing 10 items of 107 documents

Arterial Destiffening in Previously Untreated Mild Hypertensives After 1 Year of Routine Clinical Management

2016

BACKGROUND Arterial stiffness, measured with pulse wave velocity (PWV), is now classified as a marker of target organ damage (TOD) alongside left ventricular hypertrophy and moderately increased albuminuria. Interventional studies on treated hypertensive patients have shown that PWV could be improved. Our aim was to assess changes in arterial stiffness after 1 year of routine clinical practice in never-treated hypertensive patients. PATIENTS AND METHODS We studied 356 never-treated patients with suspected hypertension. After standard clinical assessment during which presence of TOD was evaluated, hypertension diagnosis was confirmed in 231 subjects who subsequently received standard routine…

AdultMalemedicine.medical_specialtyMean arterial pressureTime FactorsVasodilationPulse Wave Analysis030204 cardiovascular system & hematologyLeft ventricular hypertrophy03 medical and health sciencesVascular Stiffness0302 clinical medicineInternal medicineHeart ratePrevalenceInternal MedicineHumansMedicineArterial Pressure030212 general & internal medicinePulse wave velocityAntihypertensive Agentsbusiness.industryMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeBlood pressureSpainCase-Control StudiesHypertensionAlbuminuriaArterial stiffnessCardiologyDrug Therapy CombinationFemalemedicine.symptombusinessAmerican Journal of Hypertension
researchProduct

Transforming growth factor beta1 T29C gene polymorphism and hypertension: relationship with cardiovascular and renal damage.

2008

Distribution of T29C TGFβ1 gene polymorphism was analysed in 260 hypertensive and 134 normotensive subjects. Circulating TGFβ1 and procollagen type III levels, microalbuminuria, left ventricular geometry and function were evaluated in all the hypertensives subgrouped according to T29C TGFβ1 gene polymorphism. Circulating TGFβ1 by ELISA technique, procollagen type III by a specific radioimmunoassay, microalbuminuria by radioimmunoassay, left ventricular geometry and function by echocardiography were determined. All groups were comparable for gender, age and sex. Regarding T29C TGFβ1 gene polymorphism, prevalence of TC or CC genotypes was significantly (p < 0.05) higher in hypertensives th…

AdultMalemedicine.medical_specialtyMetabolic Clearance RateRadioimmunoassayEnzyme-Linked Immunosorbent AssayLeft ventricular hypertrophyTransforming Growth Factor beta1Procollagen type IIIElectrocardiographyInternal medicineGenotypeInternal MedicinemedicineAlbuminuriaHumansCirculating TGFβ1 Hypertension Left ventricular hypertrophy Microalbuminuria Procollagen type III TGFβ1 gene polymorphismPolymorphism GeneticRenal damagebusiness.industryRadioimmunoassayGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologyCollagen Type IIICase-Control StudiesCreatinineHypertensionMicroalbuminuriaFemaleHypertrophy Left VentricularGene polymorphismCardiology and Cardiovascular MedicinebusinessProcollagenTransforming growth factorBlood pressure
researchProduct

Enzyme Replacement Therapy Stabilized White Matter Lesion Progression in Fabry Disease

2014

<b><i>Background:</i></b> The central nervous system manifestations in Fabry disease (FD) include progressive white matter lesions (WMLs) and stroke. Due to progressive microvascular involvement, men and women with FD over 35 years of age develop WMLs. Moreover, the prevalence of stroke has been estimated to be 12 times higher in FD compared with the general population. Enzyme replacement therapy (ERT) is available and has shown beneficial effects on renal, cardiac, and peripheral nerve function in FD, but the ERT effect on the progression of WMLs, or the reduction in cerebrovascular events, remains unknown. <b><i>Methods:</i></b> The WML burd…

AdultMalemedicine.medical_specialtyPopulationPlaceboLeft ventricular hypertrophyYoung AdultLeukoencephalopathiesInternal medicinemedicineHumansEnzyme Replacement TherapyeducationStrokeAgededucation.field_of_studyVascular diseasebusiness.industryBrainEnzyme replacement therapyMiddle Agedmedicine.diseaseMagnetic Resonance ImagingWhite MatterFabry diseaseHyperintensitySurgeryIsoenzymesNeurologyalpha-GalactosidaseDisease ProgressionCardiologyFabry DiseaseFemaleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessCerebrovascular Diseases
researchProduct

Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth facto…

2005

This study has been designed to evaluate the relationship among transforming growth factor beta1 (TGFbeta1) and some measurements of diastolic function in a population of hypertensive subjects with normal left ventricular ejection fraction. We studied 67 hypertensive outpatients who according to their BMI levels were subdivided into three groups: lean (L), overweight (OW) and obese (OB) hypertensives (HT). Circulating TGFbeta1 and M- and B-mode echocardiography was determined. All hypertensives were further subgrouped, according to European Society of Cardiology Guidelines, into two subsets of patients with normal diastolic function or with diastolic dysfunction. Prevalence of left ventricu…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaHeart VentriclesEnzyme-Linked Immunosorbent Assayobesity-associated hypertension; TGFb1; left ventricular hypertrophy; left ventricular diastolic functionLeft ventricular hypertrophyTransforming Growth Factor beta1Ventricular Dysfunction LeftDiastoleRisk FactorsTransforming Growth Factor betaVentricule gaucheInternal medicineInternal MedicinemedicineHumansObesityOverproductionAgedbusiness.industryStroke VolumeNutritional statusMiddle Agedmedicine.diseaseMyocardial ContractionSettore MED/11 - Malattie Dell'Apparato CardiovascolareObesityEndocrinologyEchocardiographyHypertensionAdult Aged Biological Markers/blood Diastole Echocardiography Enzyme-Linked Immunosorbent Assay Female Heart Ventricles/physiopathology Heart Ventricles/ultrasonography Humans Hypertension/blood Hypertension/complications* Hypertension/physiopathology Hypertrophy Left Ventricular/blood Hypertrophy Left Ventricular/complications* Hypertrophy Left Ventricular/physiopathology Male Middle Aged Myocardial Contraction/physiology* Obesity/blood Obesity/complications* Obesity/physiopathology Regression Analysis Risk FactorsCardiologyRegression AnalysisFemaleHypertrophy Left VentricularbusinessVentricular fillingBiomarkersTransforming growth factorJournal of Human Hypertension
researchProduct

Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.

2013

Background: Electrocardiography (ECG) has low sensitivity for detecting left ventricular hypertrophy (LVH), while echocardiography cannot be routinely performed. Design/methods: In this study we evaluate the prevalence of LVH and diastolic dysfunction in hypertensive patients with normal ECG. We excluded patients with cardiovascular (CV) diseases, diabetes, chronic kidney disease, or presenting ECG-LVH or other ECG anomalies. The enrolled 440 hypertensive patients underwent echocardiographic examination (Acuson Sequoia 512); LV mass was indexed by body surface area (LVMI) and LVH was defined as LVMI >125 g/m2 in men and >110 g/m2 in women. Diastolic function was evaluated by mitral inflow a…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaTime FactorsEpidemiologyLeft ventricular hypertrophy hypertension electrocardiography echocardiographyDiastoleLeft ventricular hypertrophyDoppler imagingVentricular Function LeftElectrocardiographyVentricular Dysfunction LeftDiastolePredictive Value of TestsRisk FactorsInternal medicinemedicineOdds RatioPrevalenceHumanscardiovascular diseasesAgedBody surface areaChi-Square Distributionmedicine.diagnostic_testReceiver operating characteristicbusiness.industryPatient SelectionMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareConfidence intervalEchocardiography DopplerLogistic ModelsItalyROC CurveArea Under CurveHypertensionMultivariate AnalysisCardiologyFemaleHypertrophy Left VentricularCardiology and Cardiovascular MedicinebusinessElectrocardiographyKidney diseaseEuropean journal of preventive cardiology
researchProduct

Influence of metabolic syndrome on hypertension-related target organ damage

2005

MuleG, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, MongioviR, Mezzatesta G, Andronico G, Cerasola G (Universitadi Palermo, Palermo, Italy). Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257: 503-513. Objectives. The aim of our study was to analyse, in a wide group of essential hypertensive patients without diabetes mellitus, the influence of metabolic syndrome (MS) (defined according to the criteria laid down in the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults) on markers of preclinical cardiac, renal and retinal damage. Design. Cros…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternamicroalbuminuriaHeart VentriclesRetinographyLeft ventricular hypertrophyEssential hypertensionKidneyRetinametabolic syndromeHypertensive retinopathyRetinal Diseasesessential hypertension;left ventricular hypertrophy;metabolic syndrome;microalbuminuria;target organ damageInternal medicinetarget organ damageInternal MedicinemedicineAlbuminuriaHumansObesitySex DistributionNational Cholesterol Education ProgramAntihypertensive AgentsBody surface areaSettore MED/14 - Nefrologiabusiness.industryMyocardiumessential hypertensionMiddle Agedmedicine.diseaseSettore MED/11 - Malattie Dell'Apparato Cardiovascolareleft ventricular hypertrophyEndocrinologyCross-Sectional StudiesHypertensionCardiologyRegression AnalysisMicroalbuminuriaFemaleHypertrophy Left VentricularMetabolic syndromebusiness
researchProduct

Prevalence and characterization of cardiac involvement in Hunter syndrome.

2011

To assess the prevalence of cardiovascular signs and symptoms in a large group of patients with Hunter syndrome, an X-linked metabolic disorder caused by a deficiency of the lysosomal enzyme iduronate-2-sulfatase.The Hunter Outcome Survey was established to characterize the natural history of Hunter syndrome and to assess the response to enzyme replacement therapy. Echocardiographic and electrocardiographic examination results were available for 102 patients who were enzyme replacement therapy-naïve in the Hunter Outcome Survey (median age at examination, approximately 8 years) as of Jan 23, 2009.The most common cardiovascular finding was valve disease, which was present in 63% of patients.…

AdultMalemedicine.medical_specialtyTime FactorsAdolescentHeart DiseasesIduronate SulfataseLeft ventricular hypertrophyElectrocardiographyYoung AdultRisk FactorsInternal medicineGermanySurveys and QuestionnairesmedicinePrevalenceHumansYoung adultChildMucopolysaccharidosis IIRetrospective Studiesbusiness.industryMetabolic disorderIduronate-2-sulfataseRetrospective cohort studyHunter syndromeEnzyme replacement therapymedicine.diseaseUnited StatesSurgeryNatural historyEchocardiographyChild PreschoolPediatrics Perinatology and Child HealthbusinessFollow-Up StudiesThe Journal of pediatrics
researchProduct

Reduced right atrial contractile force in patients with left ventricular diastolic dysfunction: A study in human atrial fibers—contractile force and …

2017

Summary Background/Objective The aim of our study was to evaluate right heart contractile force in patients with diastolic dysfunction (DD) with preserved left heart ejection fraction undergoing cardiac surgery. We examined the contractile properties of skinned human fibers obtained from the right auricle in two groups (DD and controls). Methods Right atrial tissue from 64 patients, who were undergoing cardiac surgery, were collected before extracorporal circulation. Tissue was conserved and prepared as "skinned fibers". We exposed the dissected fibers to increasing calcium concentrations and recorded the force values. Results Patients with DD develop significantly less force at middle and …

AdultMalemedicine.medical_specialtylcsh:SurgeryDiastoleAtrial Function Right030204 cardiovascular system & hematologyLeft ventricular hypertrophy030218 nuclear medicine & medical imagingVentricular Dysfunction Left03 medical and health sciences0302 clinical medicineDiastoleInternal medicineMitral valvemedicineHumansMitral valve prolapseskinned fiberAgedPressure overloadEjection fractionbusiness.industrylcsh:RD1-811Middle Agedmedicine.diseaseCardiac surgerymedicine.anatomical_structureCase-Control StudiesAortic valve stenosisCardiologyFemaleSurgerycalcium sensitivitydiastolic dysfunctionbusinessMuscle ContractionAsian Journal of Surgery
researchProduct

Electrocardiography plus limited echocardiography in young, newly identified, hypertensives: some considerations.

2010

Adultmedicine.medical_specialtymedicine.diagnostic_testbusiness.industryCost-Benefit AnalysisAge FactorsElectrocardiography echocardiography left ventricular hypertrophy hypertensionGuidelines as TopicMiddle AgedElectrocardiographyEchocardiographyInternal medicineHypertensionInsurance Health ReimbursementInternal MedicineCardiologymedicineHumansHypertrophy Left VentricularbusinessElectrocardiographyAmerican journal of hypertension
researchProduct

Electrocardiographic and other clinical correlates of walking ability in older women

2009

Abstract The purpose of this study was to examine how resting electrocardiographic (ECG) and other clinical variables, which can be included in a routine clinical examination, predict walking ability in older women. Three hundred and twenty women (63–75 years) without overt cardiac diseases and apparent mobility limitations were studied. Measurements performed were clinical examination (standard 12-lead resting ECG, assessment of physical activity level, presence of chronic diseases, use of beta-blockers, body mass index (BMI), ability to squat, resting blood pressure) and six-minute walking test. Participants walked 533 ± 75 m in the six-minute walking test. The best electrocardiographic p…

Agingmedicine.medical_specialtyHealth (social science)Adrenergic beta-AntagonistsBlood PressurePhysical examinationSquatWalking030204 cardiovascular system & hematologyLeft ventricular hypertrophyBody Mass IndexElectrocardiography03 medical and health sciencesWalking distance0302 clinical medicinemedicineHumans030212 general & internal medicineMobility LimitationAged2. Zero hungermedicine.diagnostic_testWalking testbusiness.industryMiddle Agedmedicine.diseasePhysical activity level3. Good healthBlood pressurePhysical FitnessHypertensionExercise TestPhysical therapyFemaleGeriatrics and Gerontologybusinesshuman activitiesGerontologyBody mass indexArchives of Gerontology and Geriatrics
researchProduct